Literature DB >> 18412635

Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina.

Qing-Ping Wang1, Firas Jammoul, Agnès Duboc, Jie Gong, Manuel Simonutti, Elisabeth Dubus, Cheryl M Craft, Wen Ye, José A Sahel, Serge Picaud.   

Abstract

Vigabatrin was a major drug in the treatment of epilepsy until the discovery that it was associated with an irreversible constriction of the visual field. Nevertheless, the drug is still prescribed for infantile spasms and refractory epilepsy. Disorganization of the photoreceptor nuclear layer and cone photoreceptor damage have been described in albino rats. To investigate the vigabatrin-elicited retinal toxicity further, we examined the retinal tissue of albino mice treated with two vigabatrin doses. The higher dose did not always cause the photoreceptor layer disorganization after 1 month of treatment. However, it triggered a massive synaptic plasticity in retinal areas showing a normal layering of the retina. This plasticity was shown by the withdrawal of rod but not cone photoreceptor terminals from the outer plexiform layers towards their cell bodies. Furthermore, both rod bipolar cells and horizontal cells exhibited dendritic sprouting into the photoreceptor nuclear layer. Withdrawing rod photoreceptors appeared to form ectopic contacts with growing postsynaptic dendrites. Indeed, contacts between rods and bipolar cells, and between bipolar cells and horizontal cells were observed deep inside the outer nuclear layer. This neuronal plasticity is highly suggestive of an impaired glutamate release by photoreceptors because similar observations have been reported in different genetically modified mice with deficient synaptic transmission. Such a synaptic deficit is consistent with the decrease in glutamate concentration induced by vigabatrin. This description of the neuronal plasticity associated with vigabatrin provides new insights into its retinal toxicity in epileptic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412635      PMCID: PMC2933832          DOI: 10.1111/j.1460-9568.2008.06175.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  47 in total

Review 1.  GABAC receptor-mediated inhibition in the retina.

Authors:  Peter D Lukasiewicz; Erika D Eggers; Botir T Sagdullaev; Maureen A McCall
Journal:  Vision Res       Date:  2004-12       Impact factor: 1.886

2.  Two-photon imaging reveals somatodendritic chloride gradient in retinal ON-type bipolar cells expressing the biosensor Clomeleon.

Authors:  Jens Duebel; Silke Haverkamp; Wolfram Schleich; Guoping Feng; George J Augustine; Thomas Kuner; Thomas Euler
Journal:  Neuron       Date:  2006-01-05       Impact factor: 17.173

3.  Optimizing the indication of vigabatrin in children with refractory epilepsy.

Authors:  A Lortie; C Chiron; C Dumas; J P Mumford; O Dulac
Journal:  J Child Neurol       Date:  1997-06       Impact factor: 1.987

4.  Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.

Authors:  K Ruether; T Pung; U Kellner; B Schmitz; C Hartmann; M Seeliger
Journal:  Arch Ophthalmol       Date:  1998-06

5.  Depolarizing effect of GABA in horizontal cells of the rabbit retina.

Authors:  Carolina Varela; Luis Rivera; Román Blanco; Pedro De la Villa
Journal:  Neurosci Res       Date:  2005-08-02       Impact factor: 3.304

6.  Outer retinal dysfunction in patients treated with vigabatrin.

Authors:  C F Arndt; P Derambure; S Defoort-Dhellemmes; J C Hache
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

7.  Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.

Authors:  John M Wild; Catherine R Robson; Adrian L Jones; Ian A Cunliffe; Philip E M Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

8.  Neurite outgrowth from bipolar and horizontal cells after experimental retinal detachment.

Authors:  G P Lewis; K A Linberg; S K Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-02       Impact factor: 4.799

9.  Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

Authors:  H Daneshvar; L Racette; S G Coupland; P J Kertes; A Guberman; D Zackon
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

10.  Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

Authors:  G L Krauss; M A Johnson; N R Miller
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

View more
  20 in total

1.  New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models.

Authors:  Rebecca M Schur; Songqi Gao; Guanping Yu; Yu Chen; Akiko Maeda; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  FASEB J       Date:  2018-01-24       Impact factor: 5.191

2.  Evaluating risks for vigabatrin treatment.

Authors:  Gregory L Krauss
Journal:  Epilepsy Curr       Date:  2009 Sep-Oct       Impact factor: 7.500

3.  Evaluation of inner retinal layers with optic coherence tomography in vigabatrin-exposed patients.

Authors:  Betül Tuğcu; Mesrure Köseoğlu Bitnel; Fatma Selin Kaya; Betül Tekin Güveli; Dilek Ataklı
Journal:  Neurol Sci       Date:  2017-05-16       Impact factor: 3.307

4.  Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats.

Authors:  Firas Jammoul; Julie Dégardin; Dorothée Pain; Pauline Gondouin; Manuel Simonutti; Elisabeth Dubus; Romain Caplette; Stéphane Fouquet; Cheryl M Craft; José A Sahel; Serge Picaud
Journal:  Mol Cell Neurosci       Date:  2010-02-01       Impact factor: 4.314

5.  Vigabatrin can enhance electroretinographic responses in pigmented and albino rats.

Authors:  James D Akula; Emily R Noonan; Alessia Di Nardo; Tara L Favazza; Nan Zhang; Mustafa Sahin; Ronald M Hansen; Anne B Fulton
Journal:  Doc Ophthalmol       Date:  2015-03-12       Impact factor: 2.379

6.  Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.

Authors:  Rachel Dragas; Carol Westall; Tom Wright
Journal:  Doc Ophthalmol       Date:  2014-07-10       Impact factor: 2.379

7.  Dose-related changes in retinal function and PKC-alpha expression in rabbits on vigabatrin medication. Effect of vigabatrin in the rabbit eye.

Authors:  Ulrika Kjellström; Anitha Bruun; Fredrik Ghosh; Sten Andréasson; Vesna Ponjavic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-03       Impact factor: 3.117

8.  Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity.

Authors:  Firas Jammoul; Qingping Wang; Rima Nabbout; Caroline Coriat; Agnès Duboc; Manuel Simonutti; Elisabeth Dubus; Cheryl M Craft; Wen Ye; Stephen D Collins; Olivier Dulac; Catherine Chiron; José A Sahel; Serge Picaud
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

9.  Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors.

Authors:  Jin Yang; Matthew C Naumann; Yi-Ting Tsai; Joaquin Tosi; Deniz Erol; Chyuan-Sheng Lin; Richard J Davis; Stephen H Tsang
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

10.  Treatment of refractory complex partial seizures: role of vigabatrin.

Authors:  Elizabeth J Waterhouse; Kimberly N Mims; Soundarya N Gowda
Journal:  Neuropsychiatr Dis Treat       Date:  2009-10-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.